Current treatments for axillary hyperhidrosis

Surgeon

Volumn 2, Issue 6, 2004, Pages 311-314

  Fitzgerald, E ^a   Feeley, T M ^a   Tierney, Sean ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

Hyperhidrosis

Indexed keywords

ALUMINUM CHLORIDE; ANTIPERSPIRANT AGENT; BOTULINUM TOXIN; BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT; HEXOPYRRONIUM BROMIDE; PLACEBO; UNCLASSIFIED DRUG;

ADRENERGIC STIMULATION; AXILLA; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONSTIPATION; DROWSINESS; DRUG CHOICE; DRUG EFFICACY; DRUG MECHANISM; GLAUCOMA; HUMAN; HYPERHIDROSIS; INCIDENCE; INJECTION PAIN; INJECTION SITE; IONTOPHORESIS; MUSCLE ATROPHY; MYDRIASIS; NEUROSURGERY; PERIPHERAL NERVOUS SYSTEM; QUALITY OF LIFE; REVIEW; STANDARD; SWEAT GLAND; URINE RETENTION; XEROSTOMIA;

EID: 13644253383     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1479-666X(04)80028-3     Document Type: Review

References (50)

1. Quraishy MS, Giddings AEB. Treating hyperhidrosis: endoscopic transthoracic sympathectomy may be the best treatment. Br Med J 1993; 1221-22.
2. Moran KT, Brady MP. Surgical management of primary hyperhidrosis. Br J Surg 1991; 78: 279-83.
3. Mosek A, Korczyn A. Hyperhidrosis in the palms and soles. In: Korczyn A, editor. Handbook of Autonomic System Dysfunction New York: Marcel Dekker; p. 167-77.
4. Fitzgerald E, McCormick PH, Tierney S, Feeley TM. Botulinum toxin treatment for hyperhidrosis. IJMS 2003; 172 (1) [Suppl 1]: S28.
5. Sato K, Kang WH, Saga K, Sato KT. Biology of sweat glands and their disorders I. Normal sweat gland function. J Am Acad Dermatol 1989; 20:537-65.
6. Shih CJ, Wu JJ, Lin MT. Autonomic dysfunction in palmar hyperhidrosis. J Auton Nerv Syst 1983; 8 (1):33-43.
7. Sato K, Kang WH, Saga K, Sato KT. Biology of sweat glands and their disorders II. Disorders of sweat gland function. J Am Acad Dermatol 1989; 20:713-26.
8. Hafner J, Beer GM. Axillary sweat gland excision. Curr Probl Dermatol 2002; 30, 57-63.
9. Cheung JS, Soloman BA. Disorders of sweat glands: hyperhidrosis: unapproved treatments. Clin Dermatol 2002; 20: 628-42.
10. Togel B, Greye B, Raulin C. Current treatment strategies for hyperhidrosis: a review. Eur J Dermatol 2002; 12: 219-23.
11. Stolman LP. Treatment of hyperhidrosis. Dermatol Clin 1998 Oct; 16(4) 863-69.
12. Sato K. Hyperhidrosis. JAMA 1991; 265: 651.
13. Holzle E, Braun-Falco O. Structural changes in axillary eccrine glands following long-term treatment with aluminium chloride hexahydrate solution. Br J Dermatol 1984; 110: 399-403
14. Scholes KT, Crow KD, Ellis JP, Harman RR, Saihan EM. Axillary hyperhidrosis treated with alcoholic solution of aluminium chloride hexahydrate. Br Med J 1978; 2: 84-85.
15. Bouman HD, Lentzer EM. The treatment of hyperhidrosis of hands and feet with constant current. Am J Phys Med 1952; 31: 158-69.
16. Hill AC, Baker GF, Jansen GT. Mechanism of action of iontophoresis in the treatment of palmar hyperhidrosis. Cutis 1981; 28: 69-70.
17. Holzle E, Alberti N. Long-term efficacy and side effects of tap water iontophoresis of palmoplantar hyperhidrosis - the usefulness of home therapy. Dermatologica 1987;175: 126-35.
18. Simpson LL. Kinetic studies on the interactions between botulinum toxin type A and the cholinergic neuromuscular junction. J Pharmacol Exp Ther 1980; 212: 16-21.
19. Aoki KR. Physiology and pharmacology of therapeutic botulinum neurotoxins. Curr Probl Dermatol 2002; 30: 107-16.
20. Grazko MA, Polo KB, Jabbari B. Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology 1995; 45: 712-17.
21. Kang U, Greene P, Fahn S, Brin M, Moskowitz C, Flaster E. Double-blind placebo-controlled study of botulinum toxin injection for torticollis. Neurology 1990; 40: 1213-18.
22. Brin MF, Fahn S, Moskowitz C, Friedman A, Shale HM, Greene PE et al. Localised injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov Disord 1987; 2: 237-54.
23. Calace P, Cortese G, Piscopo R, Della Volpe G, Gagliardi V, Magli A, De Berardinis T. Treatment of blepharospasm with botulinum neurotoxin A: long-term results. Eur J Ophthalmol 2003; May: 13 (4):331-36.
24. Defazio G, Abbruzzese G, Girlanda P, Vacca L, Curra A, De Salvia R, Marchese R, Raineri R, Roselli F, Livrea P, Berardelli A. Botulinum toxin A treatment for preimary hemifacial spasm: a 10-year multicentre study. Arch Neurol 2002; 59 (3): 418-20.
25. Naumann M, Flachenecker P, Broker EB, Toyka KV, Reiners K. Botulinum toxin for palmar hyperhidrosis. Lancet 1997; 349: 252.
26. Heckmann M. Hyperhidrosis of the axilla. Curr Probl Dermatol 2002; 30: 149-55.
27. Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel-group, double-blind, placebo-controlled trial. BMJ 2001; 323: 596-99.
28. Heckmann M, Ceballos-Baumann A, Plewig G. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med 2001; 344: 488-93.
29. Naumann MK, Lowe NJ, Hamm H. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomised controlled trial. Br J Dermatol 2002; 147 (6): 1218-26.
30. Collin J, Whatling P. Treating hyperhidrosis. Surgery and botulinum toxin are treatments of choice in severe cases. BMJ 2000; 320: 1221-22.
31. Solomon BA, Hayman R. Botulinum toxin type A therapy for palmar and digital hyperhidrosis. J Am Acad Dermatol 2000; 42 1026-29.
32. Tan SR, Solish N. Long-term efficacy and quality of life in the treatment of focal hyperhidrosis with botulinum toxin A. Dermatol Surg 2002; 28 (6): 495-99.
33. Kestenholz PB, Weder W. Thoracic sympathectomy Curr Probl Dermatol 2002; 30: 64-76.
34. Orteu CH, McGregor JM, Almeyda JR, Rustin MHA. Recurrence of hyperhidrosis after endoscopic transthoracic sympathectomy - case report and review of the literature. Clin Exp Dermatol 1995; 20: 230-33.
35. Hughes J. Endoscopic sympathectomy. Proc R Soc Med 1942; 35: 585-86.
36. Rex LO, Drott C, Claes G, Gothberg G, Dalman P. The Boras experience of endoscopic thoracic sympathicotomy for palmar, axillary, facial hyperhidrosis and facial blushing. Eur J Surg Suppl 1998; 580: 23-26.
37. Chaudhuri N, Birdi I, Ritchie AJ. Current practice in thoracic sympathectomy. Hosp Med 1999; 60: 807-11.
38. Kux M. Thoracic endoscopic sympathectomy in palmar and axillary hyperhidrosis. Arch Surg 1978; 113: 264-66.
39. Edmondson RA, Banerjee AK, Rennie JA. Endoscopic transthoracic sympathectomy in the treatment of hyperhidrosis. Ann Surg 1992; 215: 289-93.
40. Adar R. Compensatory hyperhidrosis after thoracic sympathectomy. Lancet 1998; 351: 231-32.
41. Byrne J, Walsh TN, Hederman WP. Endoscopic transthoracic electrocautery of the sympathetic chain for palmar and axillary hyperhidrosis. Br J Surg 1990; 77: 1046-49.
42. Bisbal J, del Cacho C, Casalots J. Surgical treatment of axillary hyperhidrosis. Ann Plast Surg 1987; 18: 429-36.
43. Shenaq SM, Spira M, Christ J. Treatment of bilateral axillary hyperhidrosis by suction-assisted lipolysis technique. Ann Plast Surg 1987; 19: 548-51.
44. Levine IM, Harris OJ. Chemical sympathectomy. New approach to the treatment of localised hyperhidrosis. AMA Arch Derm 1955; 71 226-30.
45. Haxton HA. Chemical sympathectomy. Br Med J 1949; 1 1026-28.
46. Wilkinson HA. Percutaneous radiofrequency upper thoracic sympathectomy: a new technique. Neurosurgery 1984; 15: 811-14.
47. Chuang KS, Liou NH, Liu JC. New stereotactic technique for percutaneous thermocoagulation upper thoracic ganglionectomy in cases of palmar hyperhidrosis. Neurosurgery 1988; 22: 600-4.
48. Walker PM, Key JA, MacKay IM, Johnston KW. Phenol sympathectomy for vascular occlusive disease. Surg Gynecol Obstet 1978; 146: 741-44.
49. Dondelinger RF, Kurdziel JC. Percutaneous phenol block of the upper thoracic sympathetic chain with computed tomography guidance. A new technique. Acta Radiol 1987; 28: 511-15.
50. Adler OB, Engel A, Saranga D. Palmar hyperhidrosis treated by percutaneous transthoracic chemical sympathicolysis. Eur J Radiol 1994; 4: 57-62.